Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., a registrational Phase 2 clinical trial has been initiated in Japan ...
The total solar eclipse in North America on April 8, 2024, temporarily reset the biological clocks of some bird species, ...